Literature DB >> 10451486

Ets-1: a plausible marker of invasive potential and lymph node metastasis in human oral squamous cell carcinomas.

P Pande1, M Mathur, N K Shukla, R Ralhan.   

Abstract

The proto-oncogene Ets-1 is a transcription factor known to regulate the expression of a number of genes involved in extracellular matrix remodelling. It has been postulated to play a role in angiogenesis, cell migration, and regulation of tumour invasion. In betel and tobacco-related oral tumourigenesis, oral squamous cell carcinomas (SCCs) having a poor prognosis often exhibit extensive local disease with spread into regional lymph nodes. At present, no tumour marker is available to predict the metastatic potential of oral carcinomas. To elucidate the involvement of Ets-1 in human oral tumourigenesis, 60 cases of oral SCC, 30 potentially malignant lesions, and 30 samples of normal oral mucosa were examined by immunohistochemistry and the findings corroborated with immunoblotting. The relationship of Ets-1 expression with the degree of differentiation, lymph node metastasis, and tumour stage was determined in oral SCCs. Ets-1 was not detected in the normal oral epithelium. Among the 60 cases of oral SCC, 35 cases (58 per cent) showed positive staining for the Ets-1 protein in tumour cells. In potentially malignant lesions, 14 of 30 cases (47 per cent) showed Ets-1 immunopositivity. Ets-1 expression correlated significantly with tumour stage ( p=0.01) and lymph node metastasis ( p=0.005). The presence of Ets-1 mRNA in oral SCCs was confirmed by reverse transcription-polymerase chain reaction (RT-PCR). These findings suggest that overexpression of Ets-1 in potentially malignant lesions may be related to angiogenesis and its expression in oral SCCs may be one of the factors involved in tumour progression and lymph node metastasis. Copyright 1999 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10451486     DOI: 10.1002/(SICI)1096-9896(199909)189:1<40::AID-PATH405>3.0.CO;2-#

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  15 in total

1.  Expression of ets-1 is not affected by N-ras or H-ras during oral oncogenesis.

Authors:  Eleftherios Vairaktaris; Georgios Papageorgiou; Spyridoula Derka; Panagiota Moulavassili; Emeka Nkenke; Peter Kessler; Stavros Vassiliou; Veronica Papakosta; Sofia Spyridonidou; Antonis Vylliotis; Andreas C Lazaris; Sofia Anagnostopoulou; Constantinos Mourouzis; Christos Yapijakis; Efstratios Patsouris
Journal:  J Cancer Res Clin Oncol       Date:  2006-10-28       Impact factor: 4.553

2.  Ets1 blocks terminal differentiation of keratinocytes and induces expression of matrix metalloproteases and innate immune mediators.

Authors:  Priyadharsini Nagarajan; Shu Shien Chin; Dan Wang; Song Liu; Satrajit Sinha; Lee Ann Garrett-Sinha
Journal:  J Cell Sci       Date:  2010-10-15       Impact factor: 5.285

3.  Ets-1 and VEGF expression correlates with tumor angiogenesis, lymph node metastasis, and patient survival in esophageal squamous cell carcinoma.

Authors:  Tina Mukherjee; Anupam Kumar; Meera Mathur; Tushar Kant Chattopadhyay; Ranju Ralhan
Journal:  J Cancer Res Clin Oncol       Date:  2003-07-08       Impact factor: 4.553

4.  Differential targets of CpG island hypermethylation in primary and metastatic head and neck squamous cell carcinoma (HNSCC).

Authors:  D J Smiraglia; L T Smith; J C Lang; L J Rush; Z Dai; D E Schuller; C Plass
Journal:  J Med Genet       Date:  2003-01       Impact factor: 6.318

5.  A positive feedback loop between HER2 and ADAM12 in human head and neck cancer cells increases migration and invasion.

Authors:  V H Rao; A Kandel; D Lynch; Z Pena; N Marwaha; C Deng; P Watson; L A Hansen
Journal:  Oncogene       Date:  2011-10-10       Impact factor: 9.867

Review 6.  The biology of the Ets1 proto-oncogene.

Authors:  Jürgen Dittmer
Journal:  Mol Cancer       Date:  2003-08-20       Impact factor: 27.401

7.  Differential expression of miR-1, a putative tumor suppressing microRNA, in cancer resistant and cancer susceptible mice.

Authors:  Jessica L Fleming; Dustin L Gable; Somayeh Samadzadeh-Tarighat; Luke Cheng; Lianbo Yu; Jessica L Gillespie; Amanda Ewart Toland
Journal:  PeerJ       Date:  2013-04-16       Impact factor: 2.984

8.  ETS-1 and ETS-2 are upregulated in a transgenic mouse model of pigmented ocular neoplasm.

Authors:  G De la Houssaye; V Vieira; C Masson; F Beermann; J L Dufier; M Menasche; M Abitbol
Journal:  Mol Vis       Date:  2008-10-29       Impact factor: 2.367

9.  Ets1 induces dysplastic changes when expressed in terminally-differentiating squamous epidermal cells.

Authors:  Priyadharsini Nagarajan; Neha Parikh; Lee Ann Garrett-Sinha; Satrajit Sinha
Journal:  PLoS One       Date:  2009-01-14       Impact factor: 3.240

10.  Overexpression of the Ets-1 transcription factor in human breast cancer.

Authors:  Y Buggy; T M Maguire; G McGreal; E McDermott; A D K Hill; N O'Higgins; M J Duffy
Journal:  Br J Cancer       Date:  2004-10-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.